| The partnership, between the University and global pharmaceutical company GlaxoSmithKline (GSK), will build upon the work of researchers who have identified a molecular mechanism that plays a major role in the life-threatening liver disease that develops in a population of patients with a particular mutant gene. |
 |
| 07th September, 2012 |
Disclaimer: The disclaimer provides that such medical information is merely information not advice. If users need medical advice, they should consult a doctor or other appropriate medical professional. The disclaimer also provides that no warranties are given in relation to the medical information supplied on the website, and that no liability will accrue to the website owner or author in the event that a user suffers loss as a result of reliance upon the information.